Australia markets closed

Asensus Surgical, Inc. (ASXC)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.2600-0.0015 (-0.57%)
At close: 04:00PM EDT
0.2685 +0.01 (+3.27%)
After hours: 07:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-78,712
-78,433
-75,561
-62,462
-59,312
Depreciation & amortisation
3,759
3,729
11,076
14,111
13,699
Deferred income taxes
41
132
318
225
-1,516
Stock-based compensation
7,747
7,918
8,416
9,429
7,911
Change in working capital
1,166
3,079
-4,818
408
-7,683
Accounts receivable
-9
-1,178
-1,528
174
-447
Inventory
-633
129
-2,302
-611
-4,164
Accounts payable
-1,108
574
35
1,614
-1,758
Other working capital
-60,884
-64,188
-60,216
-42,027
-46,678
Other non-cash items
7,339
964
-1,115
-1,565
2,924
Net cash provided by operating activities
-60,387
-63,627
-58,937
-40,659
-46,675
Cash flows from investing activities
Investments in property, plant and equipment
-
-561
-1,279
-1,368
-3
Purchases of investments
-9,319
-12,268
-33,886
-122,330
0
Sales/maturities of investments
47,585
77,335
82,702
4,030
0
Net cash used for investing activities
37,769
64,506
47,537
-119,668
-3
Cash flows from financing activities
Debt repayment
-
-
-
0
0
Common stock issued
11,100
10,118
0
131,929
47,325
Other financing activities
-180
-497
-350
-1,063
-110
Net cash used provided by (used for) financing activities
10,920
9,626
-332
161,705
53,370
Net change in cash
-11,401
11,268
-11,813
1,754
6,962
Cash at beginning of period
19,879
7,470
19,283
17,529
10,567
Cash at end of period
8,181
18,738
7,470
19,283
17,529
Free cash flow
Operating cash flow
-60,387
-63,627
-58,937
-40,659
-46,675
Capital expenditure
-
-561
-1,279
-1,368
-3
Free cash flow
-60,884
-64,188
-60,216
-42,027
-46,678